Your browser doesn't support javascript.
loading
Downregulation of Interferon-γ Receptor Expression Endows Resistance to Anti-Programmed Death Protein 1 Therapy in Colorectal Cancer.
Lv, Chunxiao; Yuan, Dongfen; Cao, Yanguang.
Afiliação
  • Lv C; Department of Clinical Pharmacology, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China (C.L.) and Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (C.L., D.Y., Y.C.) and Lineberger Comprehensive Cancer Center, School of Medicine (Y.C.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Yuan D; Department of Clinical Pharmacology, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China (C.L.) and Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (C.L., D.Y., Y.C.) and Lineberger Comprehensive Cancer Center, School of Medicine (Y.C.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Cao Y; Department of Clinical Pharmacology, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China (C.L.) and Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (C.L., D.Y., Y.C.) and Lineberger Comprehensive Cancer Center, School of Medicine (Y.C.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina yanguang@unc.edu.
J Pharmacol Exp Ther ; 376(1): 21-28, 2021 01.
Article em En | MEDLINE | ID: mdl-33158943

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Receptores de Interferon / Resistencia a Medicamentos Antineoplásicos / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Receptores de Interferon / Resistencia a Medicamentos Antineoplásicos / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article